Impact and temporal trends of percutaneous coronary intervention in the drug-eluting stent versus bare metal stent eras

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 668-672

  Thompson, Craig A ^a   Kaplan, Aaron V ^a   Jayne, John E ^a   Friedman, Bruce J ^a   Hettleman, Bruce D ^a   Niles, Nathaniel W ^a   Robb, John F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; METAL; THROMBIN INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART INJURY; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METALS; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 23944510153     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.041     Document Type: Article

References (19)

1. E. Regar, P.W. Serruys, C. Bode, C. Holubarsch, J.L. Guermonprez, W. Wijns, A. Bartorelli, C. Constantini, M. Degertekin, K. Tanabe Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL) sirolimus-eluting stents inhibit restenosis irrespective of the vessel size Circulation 106 2002 1949 1956
2. P.W. Serruys, M. Degertekin, K. Tanabe, A. Abizaid, J.E. Sousa, A. Colombo, G. Guagliumi, W. Wijns, W.K. Lindeboom, J. Ligthart, P.J. de Feyter, M.C. Morice Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial Circulation 106 2002 798 803
3. A. Abizaid, M.A. Costa, D. Blanchard, M. Albertal, H. Eltchaninoff, G. Guagliumi, L. Geert-Jan, A.S. Abizaid, A.G. Sousa, E. Wuelfert Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL trial Eur Heart J 25 2004 107 112
4. P.W. Serruys, M. Degertekin, K. Tanabe, A. Abizaid, J.E. Sousa, A. Colombo, G. Guagliumi, W. Wijns, W.K. Lindeboom, J. Ligthart, P.J. de Feyter, M.C. Morice Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial Circulation 106 2002 798 803
5. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnar, R. Falotico A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
6. P.A. Lemos, A. Hoye, D. Goedhart, C.A. Arampatzis, F. Saia, W.J. van der Giessen, E. McFadden, G. Sianos, P.C. Smits, S.H. Hofma Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation 109 2004 1366 1370
7. P.A. Lemos, P.W. Serruys, R.T. van Domburg, F. Saia, C.A. Arampatzis, A. Hoye, M. Degertekin, K. Tanabe, J. Daemen, T.K. Liu Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry Circulation 109 2004 190 195
8. I. Moussa, M.B. Leon, D.S. Baim, W.W. O'Neill, J.J. Popma, M. Buchbinder, J. Midwall, C.A. Simonton, E. Keim, P. Wang, R.E. Kuntz, J.W. Moses Impact of sirolimus-eluting stents on outcome in diabetic patients a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation 109 2004 2273 2278
9. E. Schampaert, E.A. Cohen, M. Schluter, F. Reeves, M. Traboulsi, L.M. Title, R.E. Kuntz, J.J. Popma The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
10. D.R. Holmes Jr, M.B. Leon, J.W. Moses, J.J. Popma, D. Cutlip, P.J. Fitzgerald, C. Brown, T. Fischell, S.C. Wong, M. Midei, D. Snead, R.E. Kuntz Analysis of 1-year clinical outcomes in the SIRIUS trial a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
11. J. Schofer, M. Schluter, A.H. Gershlick, W. Wijns, E. Garcia, E. Schampaert, G. Breithardt Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
12. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, R.E. Kuntz Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
13. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, J.J. Popma, M.E. Russell One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent the TAXUS-IV trial Circulation 109 2004 1942 1947
14. A. Colombo, J. Drzewiecki, A. Banning, E. Grube, K. Hauptmann, S. Silber, D. Dudek, S. Fort, F. Schiele, K. Zmudka, G. Guagliumi, M.E. Russell Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
15. K. Tanabe, P.W. Serruys, E. Grube, P.C. Smits, G. Selbach, W.J. van der Giessen, M. Staberock, P. de Feyter, R. Muller, E. Regar TAXUS III trial in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation Circulation 107 2003 559 564
16. E. Grube, S. Silber, K.E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, M.E. Russell TAXUS I six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
17. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
18. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) Circulation 106 2002 1893 1900
19. E. Regar, P.A. Lemos, F. Saia, M. Degertekin, K. Tanabe, C.H. Lee, C.A. Arampatzis, A. Hoye, G. Sianos, P. de Feyter Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients Am J Cardiol 93 2004 1271 1275